T-Cell Lymphoma From CAR T-Cell Therapy—A New Safety Notice
Vinay Prasad
Abstract
This Viewpoint outlines a recent safety signal identified by the FDA concerning CAR T-cell therapy for pediatric cancer, including what is known and likely implications.
Topics & Concepts
MedicineNoticeCAR T-cell therapyLymphomaCancerImmunologyInternal medicineChimeric antigen receptorImmunotherapyLawPolitical scienceCAR-T cell therapy researchBiomedical Ethics and RegulationBiomedical and Engineering Education